Global Gene Therapy Viral Packaging Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Gene Therapy Viral Packaging Service by Type
  • 1.3.1 Overview: Global Gene Therapy Viral Packaging Service Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Gene Therapy Viral Packaging Service Consumption Value Market Share by Type in 2025
  • 1.3.3 Adeno-Associated Virus Packaging
  • 1.3.4 Lentiviral Packaging
  • 1.3.5 Adenovirus Packaging
  • 1.3.6 Other
• 1.4 Global Gene Therapy Viral Packaging Service Market by Application
  • 1.4.1 Overview: Global Gene Therapy Viral Packaging Service Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Gene Therapy
  • 1.4.3 Scientific Research
• 1.5 Global Gene Therapy Viral Packaging Service Market Size & Forecast
• 1.6 Global Gene Therapy Viral Packaging Service Market Size and Forecast by Region
  • 1.6.1 Global Gene Therapy Viral Packaging Service Market Size by Region: 2021 VS 2025 VS 2032
  • 1.6.2 Global Gene Therapy Viral Packaging Service Market Size by Region, (2021-2032)
  • 1.6.3 North America Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
  • 1.6.4 Europe Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
  • 1.6.5 Asia-Pacific Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
  • 1.6.6 South America Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)
  • 1.6.7 Middle East & Africa Gene Therapy Viral Packaging Service Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Packgene
  • 2.1.1 Packgene Details
  • 2.1.2 Packgene Major Business
  • 2.1.3 Packgene Gene Therapy Viral Packaging Service Product and Solutions
  • 2.1.4 Packgene Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Packgene Recent Developments and Future Plans
• 2.2 VectorBuilder
  • 2.2.1 VectorBuilder Details
  • 2.2.2 VectorBuilder Major Business
  • 2.2.3 VectorBuilder Gene Therapy Viral Packaging Service Product and Solutions
  • 2.2.4 VectorBuilder Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 VectorBuilder Recent Developments and Future Plans
• 2.3 Ubigene
  • 2.3.1 Ubigene Details
  • 2.3.2 Ubigene Major Business
  • 2.3.3 Ubigene Gene Therapy Viral Packaging Service Product and Solutions
  • 2.3.4 Ubigene Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Ubigene Recent Developments and Future Plans
• 2.4 GenScript
  • 2.4.1 GenScript Details
  • 2.4.2 GenScript Major Business
  • 2.4.3 GenScript Gene Therapy Viral Packaging Service Product and Solutions
  • 2.4.4 GenScript Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 GenScript Recent Developments and Future Plans
• 2.5 Abace Biology
  • 2.5.1 Abace Biology Details
  • 2.5.2 Abace Biology Major Business
  • 2.5.3 Abace Biology Gene Therapy Viral Packaging Service Product and Solutions
  • 2.5.4 Abace Biology Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Abace Biology Recent Developments and Future Plans
• 2.6 Genecfps
  • 2.6.1 Genecfps Details
  • 2.6.2 Genecfps Major Business
  • 2.6.3 Genecfps Gene Therapy Viral Packaging Service Product and Solutions
  • 2.6.4 Genecfps Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Genecfps Recent Developments and Future Plans
• 2.7 GENEWIZ
  • 2.7.1 GENEWIZ Details
  • 2.7.2 GENEWIZ Major Business
  • 2.7.3 GENEWIZ Gene Therapy Viral Packaging Service Product and Solutions
  • 2.7.4 GENEWIZ Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 GENEWIZ Recent Developments and Future Plans
• 2.8 Obio Technology
  • 2.8.1 Obio Technology Details
  • 2.8.2 Obio Technology Major Business
  • 2.8.3 Obio Technology Gene Therapy Viral Packaging Service Product and Solutions
  • 2.8.4 Obio Technology Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Obio Technology Recent Developments and Future Plans
• 2.9 Charles River Laboratories
  • 2.9.1 Charles River Laboratories Details
  • 2.9.2 Charles River Laboratories Major Business
  • 2.9.3 Charles River Laboratories Gene Therapy Viral Packaging Service Product and Solutions
  • 2.9.4 Charles River Laboratories Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Charles River Laboratories Recent Developments and Future Plans
• 2.10 Takara Bio
  • 2.10.1 Takara Bio Details
  • 2.10.2 Takara Bio Major Business
  • 2.10.3 Takara Bio Gene Therapy Viral Packaging Service Product and Solutions
  • 2.10.4 Takara Bio Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Takara Bio Recent Developments and Future Plans
• 2.11 abm
  • 2.11.1 abm Details
  • 2.11.2 abm Major Business
  • 2.11.3 abm Gene Therapy Viral Packaging Service Product and Solutions
  • 2.11.4 abm Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 abm Recent Developments and Future Plans
• 2.12 Cell Biolabs
  • 2.12.1 Cell Biolabs Details
  • 2.12.2 Cell Biolabs Major Business
  • 2.12.3 Cell Biolabs Gene Therapy Viral Packaging Service Product and Solutions
  • 2.12.4 Cell Biolabs Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Cell Biolabs Recent Developments and Future Plans
• 2.13 Cyagen
  • 2.13.1 Cyagen Details
  • 2.13.2 Cyagen Major Business
  • 2.13.3 Cyagen Gene Therapy Viral Packaging Service Product and Solutions
  • 2.13.4 Cyagen Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Cyagen Recent Developments and Future Plans
• 2.14 Vector Biolabs
  • 2.14.1 Vector Biolabs Details
  • 2.14.2 Vector Biolabs Major Business
  • 2.14.3 Vector Biolabs Gene Therapy Viral Packaging Service Product and Solutions
  • 2.14.4 Vector Biolabs Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 Vector Biolabs Recent Developments and Future Plans
• 2.15 Lonza
  • 2.15.1 Lonza Details
  • 2.15.2 Lonza Major Business
  • 2.15.3 Lonza Gene Therapy Viral Packaging Service Product and Solutions
  • 2.15.4 Lonza Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Lonza Recent Developments and Future Plans
• 2.16 Oxford BioMedica
  • 2.16.1 Oxford BioMedica Details
  • 2.16.2 Oxford BioMedica Major Business
  • 2.16.3 Oxford BioMedica Gene Therapy Viral Packaging Service Product and Solutions
  • 2.16.4 Oxford BioMedica Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 Oxford BioMedica Recent Developments and Future Plans
• 2.17 Catalent
  • 2.17.1 Catalent Details
  • 2.17.2 Catalent Major Business
  • 2.17.3 Catalent Gene Therapy Viral Packaging Service Product and Solutions
  • 2.17.4 Catalent Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 Catalent Recent Developments and Future Plans
• 2.18 Wuxi Shengji Pharmaceuticals
  • 2.18.1 Wuxi Shengji Pharmaceuticals Details
  • 2.18.2 Wuxi Shengji Pharmaceuticals Major Business
  • 2.18.3 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Product and Solutions
  • 2.18.4 Wuxi Shengji Pharmaceuticals Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 Wuxi Shengji Pharmaceuticals Recent Developments and Future Plans
• 2.19 Boten Biotech
  • 2.19.1 Boten Biotech Details
  • 2.19.2 Boten Biotech Major Business
  • 2.19.3 Boten Biotech Gene Therapy Viral Packaging Service Product and Solutions
  • 2.19.4 Boten Biotech Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.19.5 Boten Biotech Recent Developments and Future Plans
• 2.20 Cytiva
  • 2.20.1 Cytiva Details
  • 2.20.2 Cytiva Major Business
  • 2.20.3 Cytiva Gene Therapy Viral Packaging Service Product and Solutions
  • 2.20.4 Cytiva Gene Therapy Viral Packaging Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.20.5 Cytiva Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Gene Therapy Viral Packaging Service Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Gene Therapy Viral Packaging Service by Company Revenue
  • 3.2.2 Top 3 Gene Therapy Viral Packaging Service Players Market Share in 2025
  • 3.2.3 Top 6 Gene Therapy Viral Packaging Service Players Market Share in 2025
• 3.3 Gene Therapy Viral Packaging Service Market: Overall Company Footprint Analysis
  • 3.3.1 Gene Therapy Viral Packaging Service Market: Region Footprint
  • 3.3.2 Gene Therapy Viral Packaging Service Market: Company Product Type Footprint
  • 3.3.3 Gene Therapy Viral Packaging Service Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Gene Therapy Viral Packaging Service Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Gene Therapy Viral Packaging Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Gene Therapy Viral Packaging Service Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Gene Therapy Viral Packaging Service Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
• 6.2 North America Gene Therapy Viral Packaging Service Market Size by Application (2021-2032)
• 6.3 North America Gene Therapy Viral Packaging Service Market Size by Country
  • 6.3.1 North America Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
  • 6.3.2 United States Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
• 7.2 Europe Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
• 7.3 Europe Gene Therapy Viral Packaging Service Market Size by Country
  • 7.3.1 Europe Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 7.3.3 France Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Gene Therapy Viral Packaging Service Market Size by Region
  • 8.3.1 Asia-Pacific Gene Therapy Viral Packaging Service Consumption Value by Region (2021-2032)
  • 8.3.2 China Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 8.3.5 India Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
• 9.2 South America Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
• 9.3 South America Gene Therapy Viral Packaging Service Market Size by Country
  • 9.3.1 South America Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Gene Therapy Viral Packaging Service Market Size by Country
  • 10.3.1 Middle East & Africa Gene Therapy Viral Packaging Service Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Gene Therapy Viral Packaging Service Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Gene Therapy Viral Packaging Service Market Drivers
• 11.2 Gene Therapy Viral Packaging Service Market Restraints
• 11.3 Gene Therapy Viral Packaging Service Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Gene Therapy Viral Packaging Service Industry Chain
• 12.2 Gene Therapy Viral Packaging Service Upstream Analysis
• 12.3 Gene Therapy Viral Packaging Service Midstream Analysis
• 12.4 Gene Therapy Viral Packaging Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source